Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07127510 · ClinicalTrials.gov registry record
Brain NAD in Alzheimer's Disease
A clinical trial of Alzheimer Disease (AD), sponsored by Florida Atlantic University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07127510: Recruiting study of Alzheimer Disease (AD), sponsored by Florida Atlantic University.
NCT07127510 is a study of Alzheimer Disease (AD) that is actively recruiting participants, run by Florida Atlantic University. The registered enrollment target is 20 participants, below the 261-participant average among 5 other Alzheimer Disease (AD) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07127510, a study of Alzheimer Disease (AD), is actively recruiting participants, sponsored by Florida Atlantic University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who do not have Alzheimer's disease. Participants with or without Alzheimer's disease will have a brain imaging session where NAD will be measured using magnetic resonance spectroscopy (MRS). Eight months later, they will have a second, similar, brain imaging session.
Primary Outcome
NAD levels measured by 1H-MRS
Conditions Studied
Study Locations (1)
Florida
- FAU Clinical Research Unit - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-12-15 |
| Est. Completion | 2027-03 |
What NCT07127510 shows while recruiting
NCT07127510 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 261-participant average among 5 other Alzheimer Disease (AD) trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Alzheimer Disease (AD) appearing as the primary indexed condition, and to 0 interventions.
NCT07127510 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07127510 about?
NCT07127510 is a clinical study titled "Brain NAD in Alzheimer's Disease". The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who d...
What is the current status of trial NCT07127510?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-12-15. Estimated completion is 2027-03.
What conditions does trial NCT07127510 study?
This clinical trial studies the following conditions: Alzheimer Disease (AD).
Who is sponsoring clinical trial NCT07127510?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07127510 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease (AD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
RECRUITING · Phase 1
-
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
ACTIVE NOT RECRUITING
-
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
COMPLETED · Phase 2
-
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI